Followers | 71 |
Posts | 3647 |
Boards Moderated | 1 |
Alias Born | 09/16/2009 |
Thursday, February 13, 2014 2:05:28 PM
4:00
Joyce E Fox
Steven and Alexandra Cohen Children?s Medical Center
New York, NY, United States
Recombinant Human beta-glucuronidase enzyme replacement therapy for mucopolysaccharidosis type VII: report of the first patient treated.
Maybe a surge in PPS tomorrow when attendees invest in RARE
Recent RARE News
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/18/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 05:03:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 03:50:56 PM
- Ultragenyx to Participate in Investor Conferences in September • GlobeNewswire Inc. • 08/29/2024 08:30:00 PM
- Tactical Resources, a Growing North American Rare Earth Elements Company, to List on NASDAQ • Business Wire • 08/23/2024 11:00:00 AM
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/21/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:07:27 PM
- Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update • GlobeNewswire Inc. • 08/01/2024 08:05:39 PM
- Ultragenyx to Host Conference Call for Second Quarter 2024 Financial Results and Corporate Update • GlobeNewswire Inc. • 07/25/2024 08:05:00 PM
- Ultragenyx to Present GTX-102 Angelman Syndrome Program Update at the ASF Family Conference and Research Symposium • GlobeNewswire Inc. • 07/24/2024 12:00:00 PM
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/19/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:06:21 PM
- Ultragenyx Announces Successful End-of-Phase 2 Meeting with FDA for GTX-102 Angelman Syndrome Program • GlobeNewswire Inc. • 07/17/2024 08:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/12/2024 08:04:05 PM
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/20/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 06:23:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 06:22:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 06:22:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 10:31:31 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/14/2024 09:11:24 PM
- Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 06/14/2024 12:49:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 11:47:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/12/2024 09:20:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/12/2024 09:10:24 PM
- Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 06/12/2024 08:05:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM